
@article{Laughren2006,
	title = {Food and Drug Administration Perspective on Negative Symptoms in Schizophrenia as a Target for a Drug Treatment Claim},
	author = {Laughren, T. and Levin, R.},
	year = {2005},
	month = {08},
	date = {2005-08-03},
	journal = {Schizophrenia Bulletin},
	pages = {220--222},
	volume = {32},
	number = {2},
	doi = {10.1093/schbul/sbi039},
	url = {http://dx.doi.org/10.1093/schbul/sbi039},
	langid = {en}
}

@article{azorin2014,
	title = {Negative Symptoms in Schizophrenia: Where We have been and Where We are Heading},
	author = {Azorin, Jean-Michel and Belzeaux, Raoul and Adida, Marc},
	year = {2014},
	month = {06},
	date = {2014-06-16},
	journal = {CNS Neuroscience & Therapeutics},
	pages = {801--808},
	volume = {20},
	number = {9},
	doi = {10.1111/cns.12292},
	url = {http://dx.doi.org/10.1111/cns.12292},
	langid = {en}
}

@article{möller2015,
	title = {Pharmacological treatment of negative symptoms in schizophrenia},
	author = {{Möller}, {Hans-Jürgen} and Czobor, Pal},
	year = {2015},
	month = {04},
	date = {2015-04-21},
	journal = {European Archives of Psychiatry and Clinical Neuroscience},
	pages = {567--578},
	volume = {265},
	number = {7},
	doi = {10.1007/s00406-015-0596-y},
	url = {http://dx.doi.org/10.1007/s00406-015-0596-y},
	langid = {en}
}

@article{möller1998,
	title = {Novel antipsychotics and negative symptoms},
	author = {{Möller}, {Hans-Jürgen}},
	year = {1998},
	month = {03},
	date = {1998-03},
	journal = {International Clinical Psychopharmacology},
	pages = {S43--S48},
	volume = {13},
	doi = {10.1097/00004850-199803003-00008},
	url = {http://dx.doi.org/10.1097/00004850-199803003-00008},
	langid = {en}
}

@article{veerman2017,
	title = {Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review},
	author = {Veerman, Selene R. T. and Schulte, Peter F. J. and de Haan, Lieuwe},
	year = {2017},
	month = {08},
	date = {2017-08-03},
	journal = {Drugs},
	pages = {1423--1459},
	volume = {77},
	number = {13},
	doi = {10.1007/s40265-017-0789-y},
	url = {http://dx.doi.org/10.1007/s40265-017-0789-y},
	langid = {en}
}

@article{huhn2019,
	title = {Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis},
	author = {Huhn, Maximilian and Nikolakopoulou, Adriani and Schneider-Thoma, Johannes and Krause, Marc and Samara, Myrto and Peter, Natalie and Arndt, Thomas and {Bäckers}, Lio and Rothe, Philipp and Cipriani, Andrea and Davis, John and Salanti, Georgia and Leucht, Stefan},
	year = {2019},
	month = {09},
	date = {2019-09},
	journal = {The Lancet},
	pages = {939--951},
	volume = {394},
	number = {10202},
	doi = {10.1016/s0140-6736(19)31135-3},
	url = {http://dx.doi.org/10.1016/S0140-6736(19)31135-3},
	langid = {en}
}

@article{leucht2009,
	title = {Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis},
	author = {Leucht, Stefan and Corves, Caroline and Arbter, Dieter and Engel, Rolf R and Li, Chunbo and Davis, John M},
	year = {2009},
	month = {01},
	date = {2009-01},
	journal = {The Lancet},
	pages = {31--41},
	volume = {373},
	number = {9657},
	doi = {10.1016/s0140-6736(08)61764-x},
	url = {http://dx.doi.org/10.1016/S0140-6736(08)61764-X},
	langid = {en}
}

@article{darbà2011,
	title = {Eficacia de los antipsicóticos de segunda generación en el tratamiento de los síntomas negativos de esquizofrenia: un metaanálisis de ensayos clínicos aleatorizados},
	author = {{Darbà}, Josep and Minoves, {Agnès} and Rojo, Emilio and Jimenez, Francesca and Rejas, Javier},
	year = {2011},
	month = {07},
	date = {2011-07},
	journal = {Revista de Psiquiatría y Salud Mental},
	pages = {126--143},
	volume = {4},
	number = {3},
	doi = {10.1016/j.rpsm.2011.02.005},
	url = {http://dx.doi.org/10.1016/j.rpsm.2011.02.005},
	langid = {es}
}

@article{krause2018,
	title = {Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis},
	author = {Krause, Marc and Zhu, Yikang and Huhn, Maximilian and Schneider-Thoma, Johannes and Bighelli, Irene and Nikolakopoulou, Adriani and Leucht, Stefan},
	year = {2018},
	month = {01},
	date = {2018-01-24},
	journal = {European Archives of Psychiatry and Clinical Neuroscience},
	pages = {625--639},
	volume = {268},
	number = {7},
	doi = {10.1007/s00406-018-0869-3},
	url = {http://dx.doi.org/10.1007/s00406-018-0869-3},
	langid = {en}
}

@article{Kane1988,
	title = {Clozapine for the Treatment-Resistant Schizophrenic},
	author = {Kane, John},
	year = {1988},
	month = {09},
	date = {1988-09-01},
	journal = {Archives of General Psychiatry},
	pages = {789},
	volume = {45},
	number = {9},
	doi = {10.1001/archpsyc.1988.01800330013001},
	url = {http://dx.doi.org/10.1001/archpsyc.1988.01800330013001},
	langid = {en}
}

@article{meltzer1999,
	title = {The Role of Serotonin in Antipsychotic Drug Action},
	author = {Meltzer, H},
	year = {1999},
	month = {08},
	date = {1999-08},
	journal = {Neuropsychopharmacology},
	pages = {106S--115S},
	volume = {21},
	number = {2},
	doi = {10.1016/s0893-133x(99)00046-9},
	url = {http://dx.doi.org/10.1016/S0893-133X(99)00046-9},
	langid = {en}
}

@article{carpenter2000,
	title = {On Schizophrenia and New Generation Drugs},
	author = {Carpenter, W},
	year = {2000},
	month = {06},
	date = {2000-06},
	journal = {Neuropsychopharmacology},
	pages = {660--661},
	volume = {22},
	number = {6},
	doi = {10.1016/s0893-133x(99)00155-4},
	url = {http://dx.doi.org/10.1016/S0893-133X(99)00155-4}
}

@article{miller1994,
	title = {Clozapine's effect on negative symptoms in treatment-refractory schizophrenics},
	author = {Miller, Del D. and Perry, Paul J. and Cadoret, Remi J. and Andreasen, Nancy C.},
	year = {1994},
	month = {01},
	date = {1994-01},
	journal = {Comprehensive Psychiatry},
	pages = {8--15},
	volume = {35},
	number = {1},
	doi = {10.1016/0010-440x(94)90164-3},
	url = {http://dx.doi.org/10.1016/0010-440X(94)90164-3},
	langid = {en}
}

@article{Buchanan1998,
}

@article{brar1997,
	title = {The Effects of Clozapine on Negative Symptoms in Patients with Schizophrenia with Minimal Positive Symptoms},
	author = {Brar, Jaspreet and Chengappa, K. N. Roy and Parepally, Haranath and Sandman, Alan and Kreinbrook, Suzanne and Sheth, Sapna and Ganguli, Rohan},
	year = {1997},
	month = {12},
	date = {1997-12-01},
	journal = {Annals of Clinical Psychiatry},
	pages = {227--234},
	volume = {9},
	number = {4},
	doi = {10.3109/10401239709147802},
	url = {http://dx.doi.org/10.3109/10401239709147802},
	langid = {en}
}

@article{murphy2006,
	title = {Pharmacological treatment of primary negative symptoms in schizophrenia: A systematic review},
	author = {Murphy, Brendan P. and Chung, Young-Chul and Park, Tae-Won and McGorry, Patrick D.},
	year = {2006},
	month = {12},
	date = {2006-12},
	journal = {Schizophrenia Research},
	pages = {5--25},
	volume = {88},
	number = {1-3},
	doi = {10.1016/j.schres.2006.07.002},
	url = {http://dx.doi.org/10.1016/j.schres.2006.07.002},
	langid = {en}
}

@article{möller1995,
	title = {The negative component in schizophrenia},
	author = {{Möller}, H-J.},
	year = {1995},
	month = {11},
	date = {1995-11},
	journal = {Acta Psychiatrica Scandinavica},
	pages = {11--14},
	volume = {92},
	doi = {10.1111/j.1600-0447.1995.tb05938.x},
	url = {http://dx.doi.org/10.1111/j.1600-0447.1995.tb05938.x},
	langid = {en}
}

@article{peuskens1995,
	title = {Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol},
	author = {Peuskens, J.},
	year = {1995},
	month = {06},
	date = {1995-06},
	journal = {British Journal of Psychiatry},
	pages = {712--726},
	volume = {166},
	number = {6},
	doi = {10.1192/bjp.166.6.712},
	url = {http://dx.doi.org/10.1192/bjp.166.6.712},
	langid = {en}
}

@article{negative1997,
	title = {Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine},
	year = {1997},
	month = {04},
	date = {1997-04},
	journal = {American Journal of Psychiatry},
	pages = {466--474},
	volume = {154},
	number = {4},
	doi = {10.1176/ajp.154.4.466},
	url = {http://dx.doi.org/10.1176/ajp.154.4.466},
	langid = {en}
}

@article{tran1997,
	title = {Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders},
	author = {Tran, Pierre V. and Hamilton, Susan H. and Kuntz, Amy J. and Potvin, Janet H. and Andersen, Scott W. and Beasley, Charles Jr and Tollefson, Gary D.},
	year = {1997},
	month = {10},
	date = {1997-10},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {407--418},
	volume = {17},
	number = {5},
	doi = {10.1097/00004714-199710000-00010},
	url = {http://dx.doi.org/10.1097/00004714-199710000-00010},
	langid = {en}
}

@article{Alvarez2006,
	title = {A Randomized, 1-Year Follow-up Study of Olanzapine and Risperidone in the Treatment of Negative Symptoms in Outpatients with Schizophrenia},
	author = {{Álvarez}, Enrique and Ciudad, Antonio and Olivares, {José Manuel} and {Bousoño}, Manuel and {Gómez}, Juan Carlos},
	year = {2006},
	month = {06},
	date = {2006-06},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {238--249},
	volume = {26},
	number = {3},
	doi = {10.1097/01.jcp.0000222513.63767.de},
	url = {http://dx.doi.org/10.1097/01.jcp.0000222513.63767.de},
	langid = {en}
}

@article{borison1996,
	title = {ICI 204,636, an Atypical Antipsychotic},
	author = {Borison, Richard L. and Arvanitis, Lisa A. and Milier, Barbara G.},
	year = {1996},
	month = {04},
	date = {1996-04},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {158--169},
	volume = {16},
	number = {2},
	doi = {10.1097/00004714-199604000-00008},
	url = {http://dx.doi.org/10.1097/00004714-199604000-00008},
	langid = {en}
}

@article{small1997,
	title = {Quetiapine in Patients With Schizophrenia},
	author = {Small, Joyce G.},
	year = {1997},
	month = {06},
	date = {1997-06-01},
	journal = {Archives of General Psychiatry},
	pages = {549},
	volume = {54},
	number = {6},
	doi = {10.1001/archpsyc.1997.01830180067009},
	url = {http://dx.doi.org/10.1001/archpsyc.1997.01830180067009},
	langid = {en}
}

@article{arvanitis1997,
	title = {Multiple fixed doses of {\textquotedblleft}Seroquel{\textquotedblright} (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo},
	author = {Arvanitis, Lisa A. and Miller, Barbara G.},
	year = {1997},
	month = {08},
	date = {1997-08},
	journal = {Biological Psychiatry},
	pages = {233--246},
	volume = {42},
	number = {4},
	doi = {10.1016/s0006-3223(97)00190-x},
	url = {http://dx.doi.org/10.1016/S0006-3223(97)00190-X},
	langid = {en}
}

@article{tandon2004,
	title = {Quetiapine has a direct effect on the negative symptoms of schizophrenia},
	author = {Tandon, Rajiv},
	year = {2004},
	date = {2004},
	journal = {Human Psychopharmacology: Clinical and Experimental},
	pages = {559--563},
	volume = {19},
	number = {8},
	doi = {10.1002/hup.642},
	url = {http://dx.doi.org/10.1002/hup.642},
	langid = {en}
}

@article{fervaha2015,
	title = {Antipsychotics and Amotivation},
	author = {Fervaha, Gagan and Takeuchi, Hiroyoshi and Lee, Jimmy and Foussias, George and Fletcher, Paul J and Agid, Ofer and Remington, Gary},
	year = {2015},
	month = {01},
	date = {2015-01-08},
	journal = {Neuropsychopharmacology},
	pages = {1539--1548},
	volume = {40},
	number = {6},
	doi = {10.1038/npp.2015.3},
	url = {http://dx.doi.org/10.1038/npp.2015.3},
	langid = {en}
}

@article{huhn2019a,
	title = {Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis},
	author = {Huhn, Maximilian and Nikolakopoulou, Adriani and Schneider-Thoma, Johannes and Krause, Marc and Samara, Myrto and Peter, Natalie and Arndt, Thomas and {Bäckers}, Lio and Rothe, Philipp and Cipriani, Andrea and Davis, John and Salanti, Georgia and Leucht, Stefan},
	year = {2019},
	month = {09},
	date = {2019-09},
	journal = {The Lancet},
	pages = {939--951},
	volume = {394},
	number = {10202},
	doi = {10.1016/s0140-6736(19)31135-3},
	url = {http://dx.doi.org/10.1016/S0140-6736(19)31135-3},
	langid = {en}
}

@article{Möller2003,
	title = {Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality},
	author = {{Möller}, {Hans-Jürgen}},
	year = {2003},
	month = {10},
	date = {2003-10},
	journal = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
	pages = {1101--1111},
	volume = {27},
	number = {7},
	doi = {10.1016/j.pnpbp.2003.09.006},
	url = {http://dx.doi.org/10.1016/j.pnpbp.2003.09.006},
	langid = {en}
}

@article{danion1999,
	title = {Improvement of Schizophrenic Patients With Primary Negative Symptoms Treated With Amisulpride},
	author = {Danion, Jean-Marie and Rein, Werner and Fleurot, Odile and the Amisulpride Study Group, },
	year = {1999},
	month = {04},
	date = {1999-04-01},
	journal = {American Journal of Psychiatry},
	pages = {610--616},
	volume = {156},
	number = {4},
	doi = {10.1176/ajp.156.4.610},
	url = {http://dx.doi.org/10.1176/ajp.156.4.610},
	langid = {en}
}

@article{storosum2002,
	title = {Amisulpride: Is There a Treatment for Negative Symptoms in Schizophrenia Patients?},
	author = {Storosum, J. G. and Elferink, A. J.A. and van Zwieten, B. J. and van Strik, R. and Hoogendijk, W. J.G. and Broekmans, A. W.},
	year = {2002},
	month = {01},
	date = {2002-01-01},
	journal = {Schizophrenia Bulletin},
	pages = {193--202},
	volume = {28},
	number = {2},
	doi = {10.1093/oxfordjournals.schbul.a006931},
	url = {http://dx.doi.org/10.1093/oxfordjournals.schbul.a006931},
	langid = {en}
}

@article{archibald2003,
	title = {Reduction in negative symptoms of schizophrenia during long-term therapy with aripiprazole},
	author = {Archibald, D.G. and Manos, G. and Tourkodimitris, S. and Iwamoto, T. and Carson, W.H. and Stock, E. and Marcus, R.},
	year = {2003},
	month = {03},
	date = {2003-03},
	journal = {Schizophrenia Research},
	pages = {271},
	volume = {60},
	number = {1},
	doi = {10.1016/s0920-9964(03)80424-3},
	url = {http://dx.doi.org/10.1016/S0920-9964(03)80424-3},
	langid = {en}
}

@article{Kane2002,
	title = {Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder},
	author = {Kane, John M. and Carson, William H. and Saha, Anutosh R. and McQuade, Robert D. and Ingenito, Gary G. and Zimbroff, Dan L. and Ali, Mirza W.},
	year = {2002},
	month = {09},
	date = {2002-09-15},
	journal = {The Journal of Clinical Psychiatry},
	pages = {763--771},
	volume = {63},
	number = {9},
	doi = {10.4088/jcp.v63n0903},
	url = {http://dx.doi.org/10.4088/jcp.v63n0903}
}

@article{clarke2006,
	title = {Clozapine Augmentation With Aripiprazole for Negative Symptoms},
	author = {Clarke, Laura A. and Lindenmayer, Jean-Pierre and Kaushik, Saurabh},
	year = {2006},
	month = {04},
	date = {2006-04-15},
	journal = {The Journal of Clinical Psychiatry},
	pages = {675--676},
	volume = {67},
	number = {04},
	doi = {10.4088/jcp.v67n0420d},
	url = {http://dx.doi.org/10.4088/jcp.v67n0420d}
}

@article{Goff1995,
	title = {A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia},
	author = {Goff, D. C. and Amico, E. and Sarid-Segal, O. and Midha, K. K. and Hubbard, J. W.},
	year = {1995},
	month = {02},
	date = {1995-02},
	journal = {Psychopharmacology},
	pages = {417--423},
	volume = {117},
	number = {4},
	doi = {10.1007/bf02246213},
	url = {http://dx.doi.org/10.1007/BF02246213},
	langid = {en}
}

@article{Spina1994,
	title = {Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients},
	author = {Spina, E. and Domenico, P. De and Ruello, C. and Longobardo, N. and Gitto, C. and Ancione, M. and Di Rosa, A. E. and Caputi, A. P.},
	year = {1994},
	date = {1994},
	journal = {International Clinical Psychopharmacology},
	pages = {281--286},
	volume = {9},
	number = {4},
	doi = {10.1097/00004850-199400940-00007},
	url = {http://dx.doi.org/10.1097/00004850-199400940-00007},
	langid = {en}
}

@article{Buchanan1996,
	title = {Fluoxetine augmentation of clozapine treatment in patients with schizophrenia},
	year = {1996},
	month = {12},
	date = {1996-12},
	journal = {American Journal of Psychiatry},
	pages = {1625--1627},
	volume = {153},
	number = {12},
	doi = {10.1176/ajp.153.12.1625},
	url = {http://dx.doi.org/10.1176/ajp.153.12.1625},
	langid = {en}
}

@article{Silver1992,
	title = {Fluvoxamine improves negative symptoms in treated chronic schizophrenia: An add-on double-blind, placebo-controlled study},
	author = {Silver, Henry and Nassar, Ahmed},
	year = {1992},
	month = {04},
	date = {1992-04},
	journal = {Biological Psychiatry},
	pages = {698--704},
	volume = {31},
	number = {7},
	doi = {10.1016/0006-3223(92)90279-9},
	url = {http://dx.doi.org/10.1016/0006-3223(92)90279-9},
	langid = {en}
}

@article{Lu2000,
	title = {Fluvoxamine Reduces the Clozapine Dosage Needed in Refractory Schizophrenic Patients},
	author = {Lu, Mong-Liang and Lane, Hsien-Yuan and Chen, Kun-Po and Jann, Michael W. and Su, Muh-Hwan and Chang, Wen-Ho},
	year = {2000},
	month = {08},
	date = {2000-08-15},
	journal = {The Journal of Clinical Psychiatry},
	pages = {594--599},
	volume = {61},
	number = {8},
	doi = {10.4088/jcp.v61n0809},
	url = {http://dx.doi.org/10.4088/jcp.v61n0809}
}

@article{ruiu2000,
	title = {The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex},
	author = {Ruiu, S and Marchese, G and Saba, P L and Gessa, G L and Pani, L},
	year = {2000},
	month = {11},
	date = {2000-11-01},
	journal = {Molecular Psychiatry},
	pages = {673--677},
	volume = {5},
	number = {6},
	doi = {10.1038/sj.mp.4000804},
	url = {http://dx.doi.org/10.1038/sj.mp.4000804},
	langid = {en}
}

@article{Duinkerke1993,
	title = {Ritanserin, a Selective 5-HT{\textsubscript{2/1C}} Antagonist, and Negative Symptoms in Schizophrenia},
	author = {Duinkerke, S. J. and Botter, P. A. and Jansen, A. A. I. and Van Dongen, P. A. M. and Van Haaften, A. J. and Boom, A. J. and Van Laarhoven, J. H. M. and Busard, H. L. S. M.},
	year = {1993},
	month = {10},
	date = {1993-10},
	journal = {British Journal of Psychiatry},
	pages = {451--455},
	volume = {163},
	number = {4},
	doi = {10.1192/bjp.163.4.451},
	url = {http://dx.doi.org/10.1192/bjp.163.4.451},
	langid = {en}
}

@article{Akhondzadeh2008,
	title = {Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled study},
	author = {Akhondzadeh, Shahin and Malek-Hosseini, Mojgan and Ghoreishi, Aboulfazl and Raznahan, Maedeh and Rezazadeh, Shams-Ali},
	year = {2008},
	month = {12},
	date = {2008-12},
	journal = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
	pages = {1879--1883},
	volume = {32},
	number = {8},
	doi = {10.1016/j.pnpbp.2008.08.020},
	url = {http://dx.doi.org/10.1016/j.pnpbp.2008.08.020},
	langid = {en}
}

@article{Zoccali2004,
	title = {The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study},
	author = {Zoccali, Rocco and Muscatello, Maria Rosaria and Cedro, Clemente and Neri, Pietro and Torre, Diletta La and Spina, Edoardo and Rosa, Antonio Enrico Di and Meduri, Mario},
	year = {2004},
	month = {03},
	date = {2004-03},
	journal = {International Clinical Psychopharmacology},
	pages = {71--76},
	volume = {19},
	number = {2},
	doi = {10.1097/00004850-200403000-00003},
	url = {http://dx.doi.org/10.1097/00004850-200403000-00003},
	langid = {en}
}

@article{Berk2009,
	title = {Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial},
	author = {Berk, Michael and Gama, Clarissa S. and Sundram, Suresh and Hustig, Harry and Koopowitz, Les and {D'Souza}, Russell and Malloy, Hamish and Rowland, Cate and Monkhouse, Alison and Monkhouse, Andrew and Bole, Fiona and Sathiyamoorthy, Sumathy and Piskulic, Danijela and Dodd, Seetal},
	year = {2009},
	month = {04},
	date = {2009-04},
	journal = {Human Psychopharmacology: Clinical and Experimental},
	pages = {233--238},
	volume = {24},
	number = {3},
	doi = {10.1002/hup.1017},
	url = {http://dx.doi.org/10.1002/hup.1017},
	langid = {en}
}

@article{Vidal2015,
	title = {Meta-Analysis of Efficacy of Mirtazapine as an Adjunctive Treatment of Negative Symptoms in Schizophrenia},
	author = {Vidal, Carol and Reese, Carla and Fischer, Bernard A. and Chiapelli, Joshua and Himelhoch, Seth},
	year = {2015},
	month = {07},
	date = {2015-07},
	journal = {Clinical Schizophrenia & Related Psychoses},
	pages = {88--95},
	volume = {9},
	number = {2},
	doi = {10.3371/csrp.vire.030813},
	url = {http://dx.doi.org/10.3371/CSRP.VIRE.030813},
	langid = {en}
}

@article{Bodkin2005,
	title = {Double-Blind, Placebo-Controlled, Multicenter Trial of Selegiline Augmentation of Antipsychotic Medication to Treat Negative Symptoms in Outpatients With Schizophrenia},
	author = {Bodkin, J. Alexander and Siris, Samuel G. and Bermanzohn, Paul C. and Hennen, John and Cole, Jonathan O.},
	year = {2005},
	month = {02},
	date = {2005-02},
	journal = {American Journal of Psychiatry},
	pages = {388--390},
	volume = {162},
	number = {2},
	doi = {10.1176/appi.ajp.162.2.388},
	url = {http://dx.doi.org/10.1176/appi.ajp.162.2.388},
	langid = {en}
}

@article{Nikbakhat2016,
	title = {Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients with Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study},
	author = {Nikbakhat, M.-R. and Arabzadeh, S. and Zeinoddini, A. and Khalili, Z. and Rezaei, F. and Mohammadinejad, P. and Ghaleiha, A. and Akhondzadeh, S.},
	year = {2016},
	month = {02},
	date = {2016-02-22},
	journal = {Pharmacopsychiatry},
	pages = {162--169},
	volume = {49},
	number = {04},
	doi = {10.1055/s-0042-101557},
	url = {http://dx.doi.org/10.1055/s-0042-101557},
	langid = {en}
}

@article{Fusar-Poli2015,
	title = {Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials},
	author = {Fusar-Poli, Paolo and Papanastasiou, Evangelos and Stahl, Daniel and Rocchetti, Matteo and Carpenter, William and Shergill, Sukhwinder and McGuire, Philip},
	year = {2014},
	month = {12},
	date = {2014-12-20},
	journal = {Schizophrenia Bulletin},
	pages = {892--899},
	volume = {41},
	number = {4},
	doi = {10.1093/schbul/sbu170},
	url = {http://dx.doi.org/10.1093/schbul/sbu170},
	langid = {en}
}

@article{Dela2015,
	title = {Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms},
	author = {{dela Peña}, Ike and Gevorkiana, Ruzanna and Shi, Wei-Xing},
	year = {2015},
	month = {10},
	date = {2015-10},
	journal = {European Journal of Pharmacology},
	pages = {562--570},
	volume = {764},
	doi = {10.1016/j.ejphar.2015.07.044},
	url = {http://dx.doi.org/10.1016/j.ejphar.2015.07.044},
	langid = {en}
}

@article{BELL1965,
	title = {Comparison of Amphetamine Psychosis and Schizophrenia},
	author = {Bell, D. S.},
	year = {1965},
	month = {08},
	date = {1965-08},
	journal = {British Journal of Psychiatry},
	pages = {701--707},
	volume = {111},
	number = {477},
	doi = {10.1192/bjp.111.477.701},
	url = {http://dx.doi.org/10.1192/bjp.111.477.701},
	langid = {en}
}

@article{lindenmayer2013,
	title = {A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: Challenges and therapeutic opportunities},
	author = {Lindenmayer, Jean-Pierre and Nasrallah, Henry and Pucci, Michael and James, Steven and Citrome, Leslie},
	year = {2013},
	month = {07},
	date = {2013-07},
	journal = {Schizophrenia Research},
	pages = {241--252},
	volume = {147},
	number = {2-3},
	doi = {10.1016/j.schres.2013.03.019},
	url = {http://dx.doi.org/10.1016/j.schres.2013.03.019},
	langid = {en}
}

@article{Andrade2015,
	title = {Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: Systematic review and meta-analysis of randomized controlled trials},
	author = {Andrade, Chittaranjan and Kisely, Steve and Monteiro, Ingrid and Rao, Sanjay},
	year = {2015},
	month = {01},
	date = {2015-01},
	journal = {Journal of Psychiatric Research},
	pages = {14--21},
	volume = {60},
	doi = {10.1016/j.jpsychires.2014.09.013},
	url = {http://dx.doi.org/10.1016/j.jpsychires.2014.09.013},
	langid = {en}
}

@article{Conley2009,
	title = {The Effects of Galantamine on Psychopathology in Chronic Stable Schizophrenia},
	author = {Conley, Robert R. and Boggs, Douglas L. and Kelly, Deanna L. and McMahon, Robert P. and Dickinson, Dwight and Feldman, Stephanie and Ball, M. Patricia and Buchanan, Robert W.},
	year = {2009},
	month = {03},
	date = {2009-03},
	journal = {Clinical Neuropharmacology},
	pages = {69--74},
	volume = {32},
	number = {2},
	doi = {10.1097/wnf.0b013e31816f2795},
	url = {http://dx.doi.org/10.1097/WNF.0B013E31816F2795},
	langid = {en}
}


@article{freedman2008,
	title = {Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia},
	author = {Freedman, Robert and Olincy, Ann and Buchanan, Robert W. and Harris, Josette G. and Gold, James M. and Johnson, Lynn and Allensworth, Diana and Guzman-Bonilla, Alejandrina and Clement, Bettye and Ball, M. Patricia and Kutnick, Jay and Pender, Vicki and Martin, Laura F. and Stevens, Karen E. and Wagner, Brandie D. and Zerbe, Gary O. and Soti, Ferenc and Kem, William R.},
	year = {2008},
	month = {08},
	date = {2008-08},
	journal = {American Journal of Psychiatry},
	pages = {1040--1047},
	volume = {165},
	number = {8},
	doi = {10.1176/appi.ajp.2008.07071135},
	url = {http://dx.doi.org/10.1176/appi.ajp.2008.07071135},
	langid = {en}
}

@article{deutsch2013,
	title = {Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy},
	author = {Deutsch, Stephen I. and Schwartz, Barbara L. and Schooler, Nina R. and Brown, Clayton H. and Rosse, Richard B. and Rosse, Stephanie M.},
	year = {2013},
	month = {08},
	date = {2013-08},
	journal = {Schizophrenia Research},
	pages = {138--144},
	volume = {148},
	number = {1-3},
	doi = {10.1016/j.schres.2013.05.023},
	url = {http://dx.doi.org/10.1016/j.schres.2013.05.023},
	langid = {en}
}

@article{walling2015,
	title = {Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia},
	author = {Walling, David and Marder, Stephen R. and Kane, John and Fleischhacker, W. Wolfgang and Keefe, Richard S. E. and Hosford, David A. and Dvergsten, Chris and Segreti, Anthony C. and Beaver, Jessica S. and Toler, Steven M. and Jett, John E. and Dunbar, Geoffrey C.},
	year = {2015},
	month = {06},
	date = {2015-06-12},
	journal = {Schizophrenia Bulletin},
	pages = {335--343},
	volume = {42},
	number = {2},
	doi = {10.1093/schbul/sbv072},
	url = {http://dx.doi.org/10.1093/schbul/sbv072},
	langid = {en}
}

@article{singh2011,
	title = {Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia},
	author = {Singh, Surendra P. and Singh, Vidhi},
	year = {2011},
	month = {10},
	date = {2011-10},
	journal = {CNS Drugs},
	pages = {859--885},
	volume = {25},
	number = {10},
	doi = {10.2165/11586650-000000000-00000},
	url = {http://dx.doi.org/10.2165/11586650-000000000-00000},
	langid = {en}
}

@article{buchanan2007,
	title = {The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments},
	author = {Buchanan, Robert W. and Javitt, Daniel C. and Marder, Stephen R. and Schooler, Nina R. and Gold, James M. and McMahon, Robert P. and Heresco-Levy, Uriel and Carpenter, William T.},
	year = {2007},
	month = {10},
	date = {2007-10},
	journal = {American Journal of Psychiatry},
	pages = {1593--1602},
	volume = {164},
	number = {10},
	doi = {10.1176/appi.ajp.2007.06081358},
	url = {http://dx.doi.org/10.1176/appi.ajp.2007.06081358},
	langid = {en}
}

@article{moazen-zadeh2020,
	title = {Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial},
	author = {Moazen-Zadeh, Ehsan and Bayanati, Samaneh and Ziafat, Kimia and Rezaei, Farzin and Mesgarpour, Bita and Akhondzadeh, Shahin},
	year = {2020},
	month = {03},
	date = {2020-03-02},
	journal = {Journal of Psychopharmacology},
	pages = {506--513},
	volume = {34},
	number = {5},
	doi = {10.1177/0269881120909416},
	url = {http://dx.doi.org/10.1177/0269881120909416},
	langid = {en}
}

@article{redaelli2022,
	title = {Vortioxetine as adjunctive therapy in the treatment of schizophrenia},
	author = {Redaelli, Sofia and Porffy, Lilla and Oloyede, Ebenezer and Dzahini, Olubanke and Lewis, Gabriella and Lobo, Maria and Whiskey, Eromona and Shergill, Sukhi S.},
	year = {2022},
	month = {01},
	date = {2022-01},
	journal = {Therapeutic Advances in Psychopharmacology},
	pages = {204512532211100},
	volume = {12},
	doi = {10.1177/20451253221110014},
	url = {http://dx.doi.org/10.1177/20451253221110014},
	langid = {en}
}

@article{Dunayevich2017,
	title = {Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia},
	author = {Dunayevich, Eduardo and Buchanan, Robert W and Chen, Chao-Yin and Yang, Jun and Nilsen, Jon and Dietrich, Julie M and Sun, Hong and Marder, Stephen},
	year = {2017},
	month = {04},
	date = {2017-04},
	journal = {Schizophrenia Research},
	pages = {90--97},
	volume = {182},
	doi = {10.1016/j.schres.2016.10.027},
	url = {http://dx.doi.org/10.1016/j.schres.2016.10.027},
	langid = {en}
}

@article{Bugarski-Kirola2017,
	title = {Bitopertin in Negative Symptoms of Schizophrenia{\textemdash}Results From the Phase III FlashLyte and DayLyte Studies},
	author = {Bugarski-Kirola, Dragana and Blaettler, Thomas and Arango, Celso and Fleischhacker, Wolfgang W. and Garibaldi, George and Wang, Alice and Dixon, Mark and Bressan, Rodrigo A. and Nasrallah, Henry and Lawrie, Stephen and Napieralski, Julie and Ochi-Lohmann, Tania and Reid, Carol and Marder, Stephen R.},
	year = {2017},
	month = {07},
	date = {2017-07},
	journal = {Biological Psychiatry},
	pages = {8--16},
	volume = {82},
	number = {1},
	doi = {10.1016/j.biopsych.2016.11.014},
	url = {http://dx.doi.org/10.1016/j.biopsych.2016.11.014},
	langid = {en}
}

@article{Zheng2018,
	title = {Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials},
	author = {Zheng, W. and Li, X-H. and Yang, X-H. and Cai, D-B. and Ungvari, G. S. and Ng, C. H. and Wang, S-B. and Wang, Y-Y. and Ning, Y-P. and Xiang, Y-T.},
	year = {2017},
	month = {05},
	date = {2017-05-22},
	journal = {Psychological Medicine},
	pages = {72--81},
	volume = {48},
	number = {1},
	doi = {10.1017/s0033291717001271},
	url = {http://dx.doi.org/10.1017/S0033291717001271},
	langid = {en}
}

@article{Kikuchi2020,
	title = {Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?},
	author = {Kikuchi, Tetsuro},
	year = {2020},
	month = {07},
	date = {2020-07-31},
	journal = {Biomolecules},
	pages = {1134},
	volume = {10},
	number = {8},
	doi = {10.3390/biom10081134},
	url = {http://dx.doi.org/10.3390/biom10081134},
	langid = {en}
}

@article{ko2006,
	title = {Estrogen, Cognitive Function and Negative Symptoms in Female Schizophrenia},
	author = {Ko, Young-Hoon and Joe, Sook-Haeng and Cho, Woong and Park, Jeong-Hyun and Lee, Jung-Jae and Jung, In-Kwa and Kim, Leen and Kim, Seung-Hyun},
	year = {2006},
	date = {2006},
	journal = {Neuropsychobiology},
	pages = {169--175},
	volume = {53},
	number = {4},
	doi = {10.1159/000093780},
	url = {http://dx.doi.org/10.1159/000093780},
	langid = {en}
}

@article{van2013,
	title = {Testing the estrogen hypothesis of schizophrenia: Associations between cumulative estrogen exposure and cerebral structural measures},
	author = {van der Leeuw, C. and Habets, P. and Gronenschild, E. and Domen, P. and Michielse, S. and van Kroonenburgh, M. and van Os, J. and Marcelis, M.},
	year = {2013},
	month = {10},
	date = {2013-10},
	journal = {Schizophrenia Research},
	pages = {114--120},
	volume = {150},
	number = {1},
	doi = {10.1016/j.schres.2013.07.033},
	url = {http://dx.doi.org/10.1016/j.schres.2013.07.033},
	langid = {en}
}

@article{McEwen2017,
	title = {Understanding the broad influence of sex hormones and sex differences in the brain},
	author = {McEwen, Bruce S. and Milner, Teresa A.},
	year = {2016},
	month = {11},
	date = {2016-11-07},
	journal = {Journal of Neuroscience Research},
	pages = {24--39},
	volume = {95},
	number = {1-2},
	doi = {10.1002/jnr.23809},
	url = {http://dx.doi.org/10.1002/jnr.23809},
	langid = {en}
}

@article{Markham2012,
	title = {Sex steroids and schizophrenia},
	author = {Markham, Julie A.},
	year = {2011},
	month = {05},
	date = {2011-05-21},
	journal = {Reviews in Endocrine and Metabolic Disorders},
	pages = {187--207},
	volume = {13},
	number = {3},
	doi = {10.1007/s11154-011-9184-2},
	url = {http://dx.doi.org/10.1007/s11154-011-9184-2},
	langid = {en}
}

@article{Petrikis2020,
	title = {Sex hormone levels in drug-naïve, first-episode patients with psychosis},
	author = {Petrikis, Petros and Tigas, Stelios and Tzallas, Alexandros T. and Karampas, Andreas and Papadopoulos, Ioannis and Skapinakis, Petros},
	year = {2019},
	month = {12},
	date = {2019-12-11},
	journal = {International Journal of Psychiatry in Clinical Practice},
	pages = {20--24},
	volume = {24},
	number = {1},
	doi = {10.1080/13651501.2019.1699117},
	url = {http://dx.doi.org/10.1080/13651501.2019.1699117},
	langid = {en}
}

@article{Goh2021,
	title = {Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment},
	author = {Goh, Kah Kheng and Chen, Chun-Hsin and Lane, Hsien-Yuan},
	year = {2021},
	month = {02},
	date = {2021-02-21},
	journal = {International Journal of Molecular Sciences},
	pages = {2146},
	volume = {22},
	number = {4},
	doi = {10.3390/ijms22042146},
	url = {http://dx.doi.org/10.3390/ijms22042146},
	langid = {en}
}

@article{Shilling2016,
	title = {Potential of Oxytocin in the Treatment of Schizophrenia},
	author = {Shilling, Paul D. and Feifel, David},
	year = {2016},
	month = {02},
	date = {2016-02-19},
	journal = {CNS Drugs},
	pages = {193--208},
	volume = {30},
	number = {3},
	doi = {10.1007/s40263-016-0315-x},
	url = {http://dx.doi.org/10.1007/s40263-016-0315-x},
	langid = {en}
}

@article{marx2009,
	title = {Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia},
	author = {Marx, Christine E and Keefe, Richard S E and Buchanan, Robert W and Hamer, Robert M and Kilts, Jason D and Bradford, Daniel W and Strauss, Jennifer L and Naylor, Jennifer C and Payne, Victoria M and Lieberman, Jeffrey A and Savitz, Adam J and Leimone, Linda A and Dunn, Lawrence and Porcu, Patrizia and Morrow, A Leslie and Shampine, Lawrence J},
	year = {2009},
	month = {04},
	date = {2009-04-01},
	journal = {Neuropsychopharmacology},
	pages = {1885--1903},
	volume = {34},
	number = {8},
	doi = {10.1038/npp.2009.26},
	url = {http://dx.doi.org/10.1038/npp.2009.26},
	langid = {en}
}

@article{ritsner2014,
	title = {Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: An 8-week, double-blind, randomized add-on two-center trial},
	author = {Ritsner, Michael S. and Bawakny, Hisham and Kreinin, Anatoly},
	year = {2014},
	month = {02},
	date = {2014-02-18},
	journal = {Psychiatry and Clinical Neurosciences},
	pages = {432--440},
	volume = {68},
	number = {6},
	doi = {10.1111/pcn.12150},
	url = {http://dx.doi.org/10.1111/pcn.12150},
	langid = {en}
}

@article{strous2003,
	title = {Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia},
	author = {Strous, Rael D. and Maayan, Rachel and Lapidus, Raya and Stryjer, Rafael and Lustig, Michal and Kotler, Moshe and Weizman, Abraham},
	year = {2003},
	month = {02},
	date = {2003-02-01},
	journal = {Archives of General Psychiatry},
	pages = {133},
	volume = {60},
	number = {2},
	doi = {10.1001/archpsyc.60.2.133},
	url = {http://dx.doi.org/10.1001/archpsyc.60.2.133},
	langid = {en}
}

@article{usall2015,
	title = {Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial},
	author = {Usall, Judith and Huerta-Ramos, Elena and Labad, Javier and Cobo, {Jesús} and {Núñez}, Christian and Creus, Marta and {Parés}, {Gemma García} and Cuadras, Daniel and Franco, {José} and Miquel, Eva and Reyes, {Julio César} and Roca, Mercedes and , },
	year = {2015},
	month = {11},
	date = {2015-11-20},
	journal = {Schizophrenia Bulletin},
	pages = {309--317},
	volume = {42},
	number = {2},
	doi = {10.1093/schbul/sbv149},
	url = {http://dx.doi.org/10.1093/schbul/sbv149},
	langid = {en}
}

@article{cai2018,
	title = {Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications},
	author = {Cai, HuaLin and Cao, Ting and Zhou, Xiang and Yao, Jeffrey K.},
	year = {2018},
	month = {03},
	date = {2018-03-08},
	journal = {Frontiers in Psychiatry},
	volume = {9},
	doi = {10.3389/fpsyt.2018.00073},
	url = {http://dx.doi.org/10.3389/fpsyt.2018.00073}
}


@article{kulkarni2016,
	title = {Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women},
	author = {Kulkarni, Jayashri and Gavrilidis, Emorfia and Gwini, Stella M. and Worsley, Roisin and Grigg, Jasmin and Warren, Annabelle and Gurvich, Caroline and Gilbert, Heather and Berk, Michael and Davis, Susan R.},
	year = {2016},
	month = {09},
	date = {2016-09-01},
	journal = {JAMA Psychiatry},
	pages = {947},
	volume = {73},
	number = {9},
	doi = {10.1001/jamapsychiatry.2016.1383},
	url = {http://dx.doi.org/10.1001/jamapsychiatry.2016.1383},
	langid = {en}
}

@article{Gurvich2019,
	title = {Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status},
	author = {Gurvich, C. and Hudaib, A. and Gavrilidis, E and Worsley, R. and Thomas, N. and Kulkarni, J.},
	year = {2019},
	month = {02},
	date = {2019-02},
	journal = {Psychoneuroendocrinology},
	pages = {113--119},
	volume = {100},
	doi = {10.1016/j.psyneuen.2018.10.001},
	url = {http://dx.doi.org/10.1016/j.psyneuen.2018.10.001},
	langid = {en}
}

@article{oya2015,
	title = {Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials},
	author = {Oya, Kazuto and Matsuda, Yuki and Matsunaga, Shinji and Kishi, Taro and Iwata, Nakao},
	year = {2015},
	month = {08},
	date = {2015-08-25},
	journal = {European Archives of Psychiatry and Clinical Neuroscience},
	pages = {439--450},
	volume = {266},
	number = {5},
	doi = {10.1007/s00406-015-0634-9},
	url = {http://dx.doi.org/10.1007/s00406-015-0634-9},
	langid = {en}
}

@article{pawelczyk2014,
	title = {Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms},
	author = {{Pawe{\l}czyk}, Tomasz and {Ko{\l}odziej{\textendash}Kowalska}, Emilia and {Pawe{\l}czyk}, Agnieszka and {Rabe-Jab{\l}o{\'{n}}ska}, Jolanta},
	year = {2014},
	month = {12},
	date = {2014-12},
	journal = {Psychiatry Research},
	pages = {175--180},
	volume = {220},
	number = {1-2},
	doi = {10.1016/j.psychres.2014.07.071},
	url = {http://dx.doi.org/10.1016/j.psychres.2014.07.071},
	langid = {en}
}

@article{tan2022,
	title = {The Impact of Electroconvulsive Therapy on Negative Symptoms in Schizophrenia and Their Association with Clinical Outcomes},
	author = {Tan, Xiaowei and Martin, Donel and Lee, Jimmy and Tor, Phern Chern},
	year = {2022},
	month = {04},
	date = {2022-04-25},
	journal = {Brain Sciences},
	pages = {545},
	volume = {12},
	number = {5},
	doi = {10.3390/brainsci12050545},
	url = {http://dx.doi.org/10.3390/brainsci12050545},
	langid = {en}
}

@article{freitas2009,
	title = {Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia},
	author = {Freitas, Catarina and Fregni, Felipe and Pascual-Leone, Alvaro},
	year = {2009},
	month = {03},
	date = {2009-03},
	journal = {Schizophrenia Research},
	pages = {11--24},
	volume = {108},
	number = {1-3},
	doi = {10.1016/j.schres.2008.11.027},
	url = {http://dx.doi.org/10.1016/j.schres.2008.11.027},
	langid = {en}
}

@article{dlabac-delange2010,
	title = {Repetitive Transcranial Magnetic Stimulation for Negative Symptoms of Schizophrenia},
	author = {{Dlaba{\v{c}}-de Lange}, Jozarni J. and Knegtering, Rikus and Aleman, {André}},
	year = {2010},
	month = {02},
	date = {2010-02-23},
	journal = {The Journal of Clinical Psychiatry},
	pages = {411--418},
	volume = {71},
	number = {04},
	doi = {10.4088/jcp.08r04808yel},
	url = {http://dx.doi.org/10.4088/JCP.08r04808yel}
}

@article{prikryl2013,
	title = {A detailed analysis of the effect of repetitive transcranial magnetic stimulation on negative symptoms of schizophrenia: A double-blind trial},
	author = {Prikryl, Radovan and Ustohal, Libor and Prikrylova Kucerova, Hana and Kasparek, Tomas and Venclikova, Simona and Vrzalova, Michaela and Ceskova, Eva},
	year = {2013},
	month = {09},
	date = {2013-09},
	journal = {Schizophrenia Research},
	pages = {167--173},
	volume = {149},
	number = {1-3},
	doi = {10.1016/j.schres.2013.06.015},
	url = {http://dx.doi.org/10.1016/j.schres.2013.06.015},
	langid = {en}
}

@article{wobrock2015,
	title = {Left Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation for the Treatment of Schizophrenia with Predominant Negative Symptoms: A Sham-Controlled, Randomized Multicenter Trial},
	author = {Wobrock, Thomas and Guse, Birgit and Cordes, Joachim and {Wölwer}, Wolfgang and Winterer, Georg and Gaebel, Wolfgang and Langguth, Berthold and Landgrebe, Michael and Eichhammer, Peter and Frank, Elmar and Hajak, {Göran} and Ohmann, Christian and Verde, Pablo E. and Rietschel, Marcella and Ahmed, Raees and Honer, William G. and Malchow, Berend and Schneider-Axmann, Thomas and Falkai, Peter and Hasan, Alkomiet},
	year = {2015},
	month = {06},
	date = {2015-06},
	journal = {Biological Psychiatry},
	pages = {979--988},
	volume = {77},
	number = {11},
	doi = {10.1016/j.biopsych.2014.10.009},
	url = {http://dx.doi.org/10.1016/j.biopsych.2014.10.009},
	langid = {en}
}

@article{Brunelin2012,
	title = {Examining Transcranial Direct-Current Stimulation (tDCS) as a Treatment for Hallucinations in Schizophrenia},
	author = {Brunelin, Jerome and Mondino, Marine and Gassab, Leila and Haesebaert, Frederic and Gaha, Lofti and Suaud-Chagny, {Marie-Françoise} and Saoud, Mohamed and Mechri, Anwar and Poulet, Emmanuel},
	year = {2012},
	month = {07},
	date = {2012-07},
	journal = {American Journal of Psychiatry},
	pages = {719--724},
	volume = {169},
	number = {7},
	doi = {10.1176/appi.ajp.2012.11071091},
	url = {http://dx.doi.org/10.1176/appi.ajp.2012.11071091},
	langid = {en}
}

@article{pontillo2017,
	title = {Use of Transcranial Direct Stimulation in the Treatment of Negative Symptoms of Schizophrenia},
	author = {Pontillo, Maria and Costanzo, Floriana and Menghini, Deny and Averna, Roberto and Santonastaso, Ornella and Tata, Maria Cristina and Vicari, Stefano},
	year = {2017},
	month = {12},
	date = {2017-12-15},
	journal = {Clinical EEG and Neuroscience},
	pages = {18--26},
	volume = {49},
	number = {1},
	doi = {10.1177/1550059417746531},
	url = {http://dx.doi.org/10.1177/1550059417746531},
	langid = {en}
}

@article{Valiengo2020,
	title = {Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia},
	author = {Valiengo, Leandro da Costa Lane and Goerigk, Stephan and Gordon, Pedro Caldana and Padberg, Frank and Serpa, Mauricio Henriques and Koebe, Stephanie and Santos, Leonardo Afonso dos and Lovera, Roger Alberto Marcos and Carvalho, Juliana Barbosa de and van de Bilt, Martinus and Lacerda, Acioly L. T. and Elkis, Helio and Gattaz, Wagner Farid and Brunoni, Andre R.},
	year = {2020},
	month = {02},
	date = {2020-02-01},
	journal = {JAMA Psychiatry},
	pages = {121},
	volume = {77},
	number = {2},
	doi = {10.1001/jamapsychiatry.2019.3199},
	url = {http://dx.doi.org/10.1001/jamapsychiatry.2019.3199},
	langid = {en}
}

@article{correll2020,
	title = {Cariprazine in the management of negative symptoms of schizophrenia: state of the art and future perspectives},
	author = {Correll, Christoph U and Demyttenaere, Koen and Fagiolini, Andrea and Hajak, {Göran} and Pallanti, Stefano and Racagni, Giorgio and Singh, Swaran},
	year = {2020},
	month = {11},
	date = {2020-11},
	journal = {Future Neurology},
	volume = {15},
	number = {4},
	doi = {10.2217/fnl-2020-0012},
	url = {http://dx.doi.org/10.2217/fnl-2020-0012},
	langid = {en}
}

@article{Németh2017,
	title = {Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial},
	author = {{Németh}, {György} and Laszlovszky, {István} and Czobor, {Pál} and Szalai, {Erzsébet} and {Szatmári}, {Balázs} and {Harsányi}, Judit and {Barabássy}, {Ágota} and Debelle, Marc and Durgam, Suresh and Bitter, {István} and Marder, Stephen and Fleischhacker, W Wolfgang},
	year = {2017},
	month = {03},
	date = {2017-03},
	journal = {The Lancet},
	pages = {1103--1113},
	volume = {389},
	number = {10074},
	doi = {10.1016/s0140-6736(17)30060-0},
	url = {http://dx.doi.org/10.1016/S0140-6736(17)30060-0},
	langid = {en}
}

@article{Fleischhacker2019,
	title = {The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors},
	author = {Fleischhacker, Wolfgang and Galderisi, Silvana and Laszlovszky, {István} and {Szatmári}, {Balázs} and {Barabássy}, {Ágota} and Acsai, {Károly} and Szalai, {Erzsébet} and {Harsányi}, Judit and Earley, Willie and Patel, Mehul and {Németh}, {György}},
	year = {2019},
	month = {02},
	date = {2019-02-07},
	journal = {European Psychiatry},
	pages = {1--9},
	volume = {58},
	doi = {10.1016/j.eurpsy.2019.01.015},
	url = {http://dx.doi.org/10.1016/j.eurpsy.2019.01.015},
	langid = {en}
}

@article{Earley2019,
	title = {Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data},
	author = {Earley, Willie and Guo, Hua and Daniel, David and Nasrallah, Henry and Durgam, Suresh and Zhong, Yan and Patel, Mehul and {Barabássy}, {Ágota} and {Szatmári}, {Balázs} and {Németh}, {György}},
	year = {2019},
	month = {02},
	date = {2019-02},
	journal = {Schizophrenia Research},
	pages = {282--288},
	volume = {204},
	doi = {10.1016/j.schres.2018.08.020},
	url = {http://dx.doi.org/10.1016/j.schres.2018.08.020},
	langid = {en}
}

@article{Jones2020,
	title = {Emerging 5-HT receptor antagonists for the treatment of Schizophrenia},
	author = {Jones, Mackenzie T. and Strassnig, Martin T. and Harvey, Philip D.},
	year = {2020},
	month = {04},
	date = {2020-04-02},
	journal = {Expert Opinion on Emerging Drugs},
	pages = {189--200},
	volume = {25},
	number = {2},
	doi = {10.1080/14728214.2020.1773792},
	url = {http://dx.doi.org/10.1080/14728214.2020.1773792},
	langid = {en}
}

@article{Davidson2017,
	title = {Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia},
	author = {Davidson, Michael and Saoud, Jay and Staner, Corinne and Noel, Nadine and Luthringer, Elisabeth and Werner, Sandra and Reilly, Joseph and Schaffhauser, Jean-Yves and Rabinowitz, Jonathan and Weiser, Mark and Luthringer, Remy},
	year = {2017},
	month = {12},
	date = {2017-12},
	journal = {American Journal of Psychiatry},
	pages = {1195--1202},
	volume = {174},
	number = {12},
	doi = {10.1176/appi.ajp.2017.17010122},
	url = {http://dx.doi.org/10.1176/appi.ajp.2017.17010122},
	langid = {en}
}

@article{Kianirad2017,
	title = {Pimavanserin, a novel antipsychotic for management of Parkinson{\textquoteright}s disease psychosis},
	author = {Kianirad, Yasaman and Simuni, Tanya},
	year = {2017},
	month = {10},
	date = {2017-10-17},
	journal = {Expert Review of Clinical Pharmacology},
	pages = {1161--1168},
	volume = {10},
	number = {11},
	doi = {10.1080/17512433.2017.1369405},
	url = {http://dx.doi.org/10.1080/17512433.2017.1369405},
	langid = {en}
}

@article{yunusa2020,
	title = {Pimavanserin: A Novel Antipsychotic With Potentials to Address an Unmet Need of Older Adults With Dementia-Related Psychosis},
	author = {Yunusa, Ismaeel and El Helou, Marie Line and Alsahali, Saud},
	year = {2020},
	month = {02},
	date = {2020-02-26},
	journal = {Frontiers in Pharmacology},
	volume = {11},
	doi = {10.3389/fphar.2020.00087},
	url = {http://dx.doi.org/10.3389/fphar.2020.00087}
}

@article{bugarski-kirola2022,
	title = {Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe},
	author = {Bugarski-Kirola, Dragana and Arango, Celso and Fava, Maurizio and Nasrallah, Henry and Liu, I-Yuan and Abbs, Brandon and Stankovic, Srdjan},
	year = {2022},
	month = {01},
	date = {2022-01},
	journal = {The Lancet Psychiatry},
	pages = {46--58},
	volume = {9},
	number = {1},
	doi = {10.1016/s2215-0366(21)00386-2},
	url = {http://dx.doi.org/10.1016/S2215-0366(21)00386-2},
	langid = {en}
}
